Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group.
Grant
D
D
University of Western Ontario, London, Canada.
Rochon
J
J
Levy
G
G
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004304:Dosage Forms; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use; D012086:Reoperation; D015996:Survival Rate
D000961:Antilymphocyte Serum; D004304:Dosage Forms; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D008775:Methylprednisolone